Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan

Reuters

07/21

<a href="https://laohu8.com/S/THRD">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan

Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2553447619"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553447619\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553447619?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-21 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553447619","market":"fut","top_or_hot":-1,"title":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/THRD\">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThird Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-21 19:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/THRD\">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"THRD","symbol_name":"Third Harmonic Bio, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL8CRwXW:1","article_id":"2553447619","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553447619","pubTimestamp":1753095948,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12 of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15 of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"THRD":"Third Harmonic Bio, Inc.","BK4007":"制药"},"translate_title":"Third Harmonic Bio Inc.宣布自愿从纳斯达克退市并计划公司解散","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THRD":0.9},"content_text":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    \n\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}